Techno Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	705.16	725.18	696.02	642.86	674.15
Other Revenue	0.93	0.54	0.99	2.18	1.3
Revenue	706.09	725.72	697.01	645.04	675.45
Revenue Growth (YoY)	-2.71%	4.12%	8.06%	-4.50%	6.94%
Cost of Revenue	454.87	494.39	465.5	414.33	418.31
Gross Profit	251.22	231.33	231.51	230.71	257.13
Selling, General & Admin	205.48	227.09	225.24	212.3	201.81
Operating Expenses	205.49	227.46	224.63	212.15	202.01
Operating Income	45.73	3.87	6.88	18.56	55.12
Interest Expense	-13.32	-19.97	-15.58	-6.27	-5.02
Interest & Investment Income	0.3	0.29	-	-	-
Currency Exchange Gain (Loss)	1.49	4.44	5.66	4.69	-4.91
EBT Excluding Unusual Items	34.19	-11.36	-3.05	16.97	45.19
Asset Writedown	-	-14.94	-	-	-
Pretax Income	34.19	-26.3	-3.05	16.97	45.19
Income Tax Expense	12.12	4.83	8.88	5.89	15.45
Earnings From Continuing Operations	22.07	-31.14	-11.92	11.08	29.74
Minority Interest in Earnings	5.45	9.5	7.44	1.91	0.76
Net Income	27.51	-21.64	-4.49	12.99	30.5
Net Income to Common	27.51	-21.64	-4.49	12.99	30.5
Net Income Growth	-	-	-	-57.41%	-25.74%
Shares Outstanding (Basic)	308	308	308	308	308
Shares Outstanding (Diluted)	308	308	308	314	308
Shares Change (YoY)	-	-	-1.94%	1.98%	-0.27%
EPS (Basic)	0.09	-0.07	-0.01	0.04	0.10
EPS (Diluted)	0.09	-0.07	-0.01	0.04	0.10
EPS Growth	-	-	-	-58.18%	-25.56%
Free Cash Flow	438.24	454.01	-71.97	-110.37	-48.65
Free Cash Flow Per Share	1.42	1.47	-0.23	-0.35	-0.16
Dividend Per Share	-	-	0.033	0.050	0.085
Dividend Growth	-	-	-34.00%	-41.18%	-15.00%
Gross Margin	35.58%	31.88%	33.21%	35.77%	38.07%
Operating Margin	6.48%	0.53%	0.99%	2.88%	8.16%
Profit Margin	3.90%	-2.98%	-0.64%	2.01%	4.52%
Free Cash Flow Margin	62.07%	62.56%	-10.32%	-17.11%	-7.20%
EBITDA	74.89	36.29	34.2	34.41	68.79
EBITDA Margin	10.61%	5.00%	4.91%	5.33%	10.18%
D&A For EBITDA	29.17	32.42	27.32	15.85	13.67
EBIT	45.73	3.87	6.88	18.56	55.12
EBIT Margin	6.48%	0.53%	0.99%	2.88%	8.16%
Effective Tax Rate	35.45%	-	-	34.70%	34.19%
Revenue as Reported	707.58	730.16	702.67	649.73	670.54

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.